Chad A. Coberly

CEO at Tetra Therapeutics

Chad has more than 25 years of experience, primarily in the areas of biotech regulatory, clinical, compliance, intellectual property, business development, litigation, and general corporate legal affairs. Prior to joining Tetra, he served as the Chief Clinical & Legal Officer for Cohera Medical, where he led the clinical, regulatory, and legal aspects of commercialization of the first-ever approved 100% synthetic absorbable surgical adhesive. He brings intellectual property experience from the law firm of Howard and Howard, and experience from Zassi Medical and the Surgical Group of the Stryker Corporation where he held regulatory and legal-related positions.

Chad holds a JD from Michigan State University and a bachelor’s degree in biomedical engineering from Tulane University. He also has conducted MBA studies at Boston University. He is admitted to practice before the U.S. Patent and Trademark Office and is a member of the Michigan Bar.

Links

Timeline

  • CEO

    Current role

View in org chart